Cargando…
Yeast as a Model to Find New Drugs and Drug Targets for VPS13-Dependent Neurodegenerative Diseases
Mutations in human VPS13A-D genes result in rare neurological diseases, including chorea-acanthocytosis. The pathogenesis of these diseases is poorly understood, and no effective treatment is available. As VPS13 genes are evolutionarily conserved, the effects of the pathogenic mutations could be stu...
Autores principales: | Kaminska, Joanna, Soczewka, Piotr, Rzepnikowska, Weronika, Zoladek, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104724/ https://www.ncbi.nlm.nih.gov/pubmed/35563497 http://dx.doi.org/10.3390/ijms23095106 |
Ejemplares similares
-
Flavonoids as Potential Drugs for VPS13-Dependent Rare Neurodegenerative Diseases
por: Soczewka, Piotr, et al.
Publicado: (2020) -
Targeting Copper Homeostasis Improves Functioning of vps13Δ Yeast Mutant Cells, a Model of VPS13-Related Diseases
por: Soczewka, Piotr, et al.
Publicado: (2021) -
The GTPase Arf1 Is a Determinant of Yeast Vps13 Localization to the Golgi Apparatus
por: Kolakowski, Damian, et al.
Publicado: (2021) -
Yeast-model-based study identified myosin- and calcium-dependent calmodulin signalling as a potential target for drug intervention in chorea-acanthocytosis
por: Soczewka, Piotr, et al.
Publicado: (2019) -
Partial Inhibition of Calcineurin Activity by Rcn2 as a Potential Remedy for Vps13 Deficiency
por: Wardaszka, Patrycja, et al.
Publicado: (2021)